Tzu Cancer Therapeutics

Tzu Cancer Therapeutics brings good news: with the acquisition of Fetch B.V., the entire chain for isolating and characterizing Circulating Tumor Cells — which play a key role in cancer metastasis — is now under one roof. Read our full press release: tzu.nl/acquisition-fe…

Tzu Cancer Therapeutics marked its journey since July 2024 with a Summer Party at Amsterdam Science Park. Guests enjoyed drinks, food, and a special goodie bag, including a Tzu-engraved knife inspired by Sun Tzu’s "The Art of War."

Tzu Cancer Therapeutics is named after Sun Tzu (544 - 496 BC) who wrote in The Art of War: "Know the enemy and know yourself; in a hundred battles you will never be defeated."

Knowledge of the tumor cells on their way to cause metastases is the basis for therapy.

Tzu Cancer Therapeutics is a startup company in Amsterdam. The goal is deep molecular analysis of Circulating Tumor Cells (CTCs), that are on their way to cause metastases, and use that as basis for personalized cancer therapy.